Your browser doesn't support javascript.
loading
Bispecific T-Cell Engaging Antibodies Against MUC16 Demonstrate Efficacy Against Ovarian Cancer in Monotherapy and in Combination With PD-1 and VEGF Inhibition.
Yeku, Oladapo O; Rao, Thapi Dharma; Laster, Ian; Kononenko, Artem; Purdon, Terence J; Wang, Pei; Cui, Ziyou; Liu, Hong; Brentjens, Renier J; Spriggs, David.
Afiliação
  • Yeku OO; Division of Hematology-Oncology, Massachusetts General Hospital, Boston, MA, United States.
  • Rao TD; Department of Medicine, Massachusetts General Hospital, Boston, MA, United States.
  • Laster I; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
  • Kononenko A; Division of Hematology-Oncology, Massachusetts General Hospital, Boston, MA, United States.
  • Purdon TJ; Division of Hematology-Oncology, Massachusetts General Hospital, Boston, MA, United States.
  • Wang P; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
  • Cui Z; Eureka Therapeutics Inc., Emeryville, California, United States.
  • Liu H; Eureka Therapeutics Inc., Emeryville, California, United States.
  • Brentjens RJ; Eureka Therapeutics Inc., Emeryville, California, United States.
  • Spriggs D; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
Front Immunol ; 12: 663379, 2021.
Article em En | MEDLINE | ID: mdl-33936101
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Anticorpos Biespecíficos / Antineoplásicos Hormonais / Inibidores de Checkpoint Imunológico / Proteínas de Membrana Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Anticorpos Biespecíficos / Antineoplásicos Hormonais / Inibidores de Checkpoint Imunológico / Proteínas de Membrana Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos